505 (B) 2

by Bioxcel C. Big Pharma Expert

The industry faces a growing challenge of higher regulatory hurdles in developing novel therapeutics in complex, chronic, and rare diseases.

Recommended Features

18000+ Active Pharmaceutical Ingredients Characterized
100+Disease Indications Analyyzed
Repurposing
Reformulation
Valuse Creation for Assets

Learn more about 505 (B) 2»

Review on 505 (B) 2

BioXcel's live first-in-class cloud based big data analytics platform, PharmGPSTM has been applied to the known active pharmaceutical ingredients (APIs) space, by leveraging the inherent properties of these chemicals and reformulating and repurposing them to satisfy unmet medical needs. PharmGPSTM Repurposing and Reformulation Suite facilitates the design of repurposing known active pharmaceutical ingredients for over 100 disease indications in the context of their unmet needs, current pipeline and in-line marketed drugs so that optimal applications can be prioritized for the right disease and the right delivery mechanism.

Related to 505 (B) 2

The Cure For All Diseases by Hulda Clark Ph.D., N.D.

There is a lot of useful everyday health and wellness advice found in Dr. Clark's book, The Cure For All Diseases. I think every home should have a copy. Her...